US Patent Issued to Gilead Sciences on Sept. 30 for "Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,150, issued on Sept. 30, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs" was invented by Gerard Jensen (Brea, Calif.), Youngri Kim (Anaheim, Calif.), Kian Yong Lee (Diamond Bar, Calif.), Huy Pham (Orange, Calif.), Thomas Upton (Huntington Beach, Calif.) and Stephanie Yang (Arcadia, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides pharmaceutical formulations of the compound of Formula I:or a pharmaceutically acceptable salt thereof."

The patent was filed on May 25, 2022, under Application No. 17/824,288.

*For further information, i...